1. Home
  2. RLAY vs PLUS Comparison

RLAY vs PLUS Comparison

Compare RLAY & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$13.50

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo ePlus inc.

PLUS

ePlus inc.

HOLD

Current Price

$84.45

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
PLUS
Founded
2015
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
RLAY
PLUS
Price
$13.50
$84.45
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$19.50
N/A
AVG Volume (30 Days)
3.8M
148.6K
Earning Date
05-05-2026
05-21-2026
Dividend Yield
N/A
1.20%
EPS Growth
31.78
N/A
EPS
N/A
4.08
Revenue
$15,355,000.00
$2,068,789,000.00
Revenue This Year
N/A
$19.83
Revenue Next Year
$324.03
$4.36
P/E Ratio
N/A
$20.07
Revenue Growth
53.44
N/A
52 Week Low
$2.83
$62.11
52 Week High
$17.32
$93.98

Technical Indicators

Market Signals
Indicator
RLAY
PLUS
Relative Strength Index (RSI) 54.25 52.13
Support Level $11.75 $70.97
Resistance Level $17.32 $91.48
Average True Range (ATR) 0.94 3.29
MACD 0.01 -0.49
Stochastic Oscillator 49.61 37.16

Price Performance

Historical Comparison
RLAY
PLUS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: